RPRX

Royalty Pharma PLC

Price

$63.75

return (12m)

76.42%

p/e

33.34

p/bv

2.77

DIVIDEND YIELD

1.53%

RPRX price

Royalty Pharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment RPRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

9.55%

3 months

8.03%

1 year

76.42%

2 years

144.16%

5 years

90.29%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals RPRX

Valuation

P/E

33.34

Sector -139.59

Industry -1,521.14

P/BV

2.77

Sector -10.01

Industry -43.43

P/Revenue (PSR)

10.67

Sector -11.28

Industry -

EV/EBITDA

192.32

Sector -1,029.54

Industry -

EV/EBIT

193.74

Sector -570.51

Industry -

P/EBITDA

15.78

Sector -110.80

Industry -580.65

P/EBIT

15.82

Sector -128.80

Industry -546.11

P/Total Assets

1.37

Sector 0.14

Industry 0.40

P/Net Current Assets

-3.27

Sector -10.50

Industry -

P/Working Capital

23.88

Sector -

Industry -

EPS

1.82

Sector -9,547.75

Industry -20,613.44

BVPS

21.99

Sector -8,471.08

Industry -6,015.22

Efficiency

Gross Margin

100.00%

Sector 0.87%

Industry -0.03%

EBITDA Margin

26.17%

Sector -278.41%

Industry -

EBIT Margin

59.61%

Sector -7.22%

Industry -10.83%

Net Profit Margins

32.02%

Sector -2.47%

Industry -11.89%

Asset Turnover

0.03

Sector 0.01

Industry -

Profitability

ROE

8.30%

Sector -1,326.55%

Industry -67.35%

ROA

4.10%

Sector -8.22%

Industry -16.16%

ROIC

2.86%

Sector -12.38%

Industry -

Dividends

Dividend yield

1.53%

Sector 0.26%

Industry -

Payout

51.01%

Sector 5.40%

Industry -

Debt

Current Ratio

2.80

Sector -

Industry -

Net Debt / EBITDA

38.86

Sector -157.78

Industry -14.56

Net Debt / EBIT

39.15

Sector -105.14

Industry -16.14

Net Debt / Equity

0.70

Sector -0.81

Industry -0.65

Gross Debt / Equity

0.88

Sector -0.24

Industry -0.78

Equity/Assets

0.49

Sector -0.03

Industry -0.11

Liabilities/Assets

0.51

Sector 0.36

Industry -0.01

Growth

5Y Revenue CAGR

2.07%

Sector -

Industry -

5Y Earnings CAGR

5.55%

Sector -

Industry -

Fundamentals RPRX

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Royalty Pharma ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$63.75

Fair Value

$30.01

Upside

-52.93%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
RPRX Royalty Pharma PLC	$63.75	73.40%	1.53%	33.34	2.77	8.30%	32.02%
PSEC Prospect Capital Corporation	$1.49	-35.25%	31.06%	5.26	0.28	5.25%	30.79%
GOLD Gold.com, Inc.	$38.66	47.51%	4.64%	12.85	1.21	9.40%	0.32%
PFLT PennantPark Floating Rate Capital Ltd.	$6.42	-16.81%	17.47%	13.03	0.64	4.94%	62.69%
CSWC Capital Southwest Corporation	$22.38	24.12%	11.22%	12.55	1.31	10.46%	72.73%
STT State Street Corporation	$167.84	50.26%	2.04%	14.36	1.64	11.44%	14.09%
OCSL Oaktree Specialty Lending Corporation	$11.45	-6.78%	12.57%	24.38	0.74	3.05%	15.75%
PNNT PennantPark Investment Corporation	$2.88	-45.32%	31.12%	19.88	0.47	2.37%	16.48%
GBDC Golub Capital BDC Inc.	$12.19	-3.50%	11.31%	18.51	0.86	4.64%	48.49%
MAGS Magal Security Systems Ltd.	$70.45	9.71%	1.36%	176.87	21.10	11.93%	14.66%
JPM JPMorgan Chase & Co.	$336.54	16.04%	1.79%	13.80	2.41	17.47%	32.63%
NU Nu Holdings (NuBank)	$14.73	-3.35%	0.00%	20.81	5.67	27.22%	18.61%
MA Mastercard Incorporated	$633.21	11.69%	0.55%	33.41	96.89	289.99%	46.34%
BAC Bank of America Corporation	$51.08	1.27%	2.28%	11.46	1.26	10.95%	27.34%
INTR Inter & Co. Inc. Class A Common Shares (Banco Inter)	$6.74	-28.53%	1.59%	10.82	1.56	14.43%	9.28%
BRK-B Berkshire Hathaway INC.	$546.97	11.33%	0.00%	13.61	1.56	11.46%	22.34%
HSBC HSBC Holdings PLC	$91.89	45.42%	3.99%	12.86	1.65	12.84%	18.78%
BRK-A Berkshire Hathaway INC.	$820,413.27	11.29%	0.00%	13.61	1.56	11.45%	22.32%
BLK BlackRock Inc.	$1,137.29	2.84%	1.97%	19.97	0.00	-%	32.81%
C Citigroup Inc.	$122.51	27.34%	1.99%	11.85	0.99	8.32%	19.53%
RY ROYAL BANK OF CANADA	$202.06	42.53%	2.34%	106.66	14.68	13.76%	15.75%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

RPRX - Historical Dividends

Current Dividend Yield

1.53%

5-year average Dividend Yield

2.52%

Current Payout

51.01%

5-year average Payout

187.49%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	08/13/2026	09/10/2026	0.23500000
Dividends	05/14/2026	06/10/2026	0.24000000
Dividends	02/19/2026	03/10/2026	0.23500000
Dividends	11/13/2025	12/10/2025	0.22000000
Dividends	08/14/2025	09/10/2025	0.22000000
Dividends	05/15/2025	06/10/2025	0.22000000
Dividends	02/20/2025	03/10/2025	0.22000000
Dividends	11/14/2024	12/10/2024	0.21000000
Dividends	08/15/2024	09/13/2024	0.21000000
Dividends	05/15/2024	06/14/2024	0.21000000
Dividends	02/14/2024	03/15/2024	0.21000000
Dividends	11/15/2023	12/15/2023	0.20000000
Dividends	08/16/2023	09/15/2023	0.20000000
Dividends	05/17/2023	06/15/2023	0.20000000
Dividends	02/14/2023	03/15/2023	0.20000000
Dividends	11/16/2022	12/15/2022	0.19000000
Dividends	08/17/2022	09/15/2022	0.19000000
Dividends	05/18/2022	06/15/2022	0.19000000
Dividends	02/16/2022	03/15/2022	0.19000000
Dividends	11/17/2021	12/15/2021	0.17000000
Dividends	08/18/2021	09/15/2021	0.17000000
Dividends	05/18/2021	06/15/2021	0.17000000
Dividends	02/17/2021	03/15/2021	0.17000000
Dividends	11/18/2020	12/15/2020	0.15000000
Dividends	09/11/2020	09/30/2020	0.15000000

ABOUT Royalty Pharma

Royalty Pharma PLC

Average Investor10 user rating

4.0 (4 people)

United States

6 years

Founded: 2020

2020

Time since IPO - 6 years

100

Employees

Royalty Pharma PLC (United States) is listed on the Nasdaq and has a market capitalization of $27.07 billion, with shareholders equity totaling $9.79 billion.

The company employs approximately 100 people and operates in the Financial sector, within the Auxiliary Activities of Financial Services industry.

Over the past 12 months, Royalty Pharma PLC reported $2.54 billion in revenue, generating net income of $812.00 million.

Key financial metrics include a P/E ratio of 33.34, a price-to-book (P/B) ratio of 2.77, and a trailing twelve-month dividend yield of 1.53%.

The company trades under the ticker RPRX.

Market cap

$27.07 billion

Net worth

$9.79 billion

$9,785,714,000.00

Assets

$19.82 billion

$19,819,771,000.00

Total Shares Outstanding

445.06 million

445,064,000

Average Daily Trading Volume

$3.07 million

$3,069,378.52

Sector

Financial

Industry

Auxiliary Activities of Financial Services

RPRX

revenue by Business Segment Royalty Pharma

Revenue by Region Royalty Pharma

RPRX revenue and profits

Financial Results RPRX

DRAG THE FRAME TO SEE MORE DATA

RPRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BRK-A - Berkshire Hathaway

$820,413.27 11,57% (12M)

P/E

13.61

0.00%

ROE

11.45%

P/BV

1.56

BRK-B - Berkshire Hathaway

$546.97 11,59% (12M)

P/E

13.61

0.00%

ROE

11.46%

P/BV

1.56

JPM - JPMorgan

$336.54 17,04% (12M)

P/E

13.80

1.79%

ROE

17.47%

P/BV

2.41

SNEX - StoneX Group

$57.30 29,22% (12M)

P/E

12.72

0.00%

ROE

18.53%

P/BV

2.36

GS - Goldman Sachs

$891.30 20,52% (12M)

P/E

12.28

2.00%

ROE

17.64%

P/BV

2.17

HSBC - HSBC

$91.89 44,91% (12M)

P/E

12.86

3.99%

ROE

12.84%

P/BV

1.65

MS - Morgan Stanley

$183.97 18,84% (12M)

P/E

14.44

2.26%

ROE

18.08%

P/BV

2.61

WFC - Wells Fargo

$83.01 0,40% (12M)

P/E

11.41

2.24%

ROE

12.54%

P/BV

1.43